Aligos Therapeutics announced that it will effect a 1-for-25 reverse stock split of its shares of common stock. The reverse stock split will become effective at 12:01 am ET on Monday, August 19, 2024. The Company’s common stock is expected begin trading on the Nasdaq Capital Market under the same symbol on a split-adjusted basis at the market open on August 19, 2024 with the new CUSIP number 01626L 204.
Elevate Your Investing Strategy:
- Take advantage of TipRanks Premium at 55% off! Unlock powerful investing tools, advanced data, and expert analyst insights to help you invest with confidence.
Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>
Read More on ALGS:
- Aligos Therapeutics Announces Reverse Stock Split
- Aligos Therapeutics Expands Board with New Director Appointments
- Aligos Therapeutics Strengthens Board with Two New Independent Directors
- Aligos Therapeutics reports Q2 EPS 3c, one estimate (16c)
- Aligos Therapeutics to Announce 2nd Quarter 2024 Financial Results on August 6, 2024